Clinical Trial: Calcium and Vitamin D to Optimize Bone Mass in Boys With Risperidone-induced Hyperprolactinemia
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Counteracting Risperidone-Induced Hyperprolactinemia in Youths
Brief Summary: The purpose of this study is to determine whether calcium and vitamin D supplementation, over a nine-month period, optimizes bone mineralization in boys with risperidone-induced hyperprolactinemia. We hypothesize that, by the end of the stuy, children in the supplementation group will have higher bone mineral density compared to those in the placebo group.
Detailed Summary:
Sponsor: University of Iowa
Current Primary Outcome: Trabecular bone mineral density in the ultradistal radius [ Time Frame: 9 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome: total body bone mineral content [ Time Frame: 9 months ]
Original Secondary Outcome: Same as current
Information By: University of Iowa
Dates:
Date Received: November 25, 2008
Date Started: November 2008
Date Completion:
Last Updated: April 2, 2014
Last Verified: April 2014